Skip to content

Pain control in bone marrow aspiration and biopsy

Determining and comparing the effectiveness of intravenous injection of apotel, promethazine syrup and local anesthesia with intravenous injection of pethidine and local anesthesia in controlling pain in patients candidate for bone marrow aspiration and biopsy.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200427047215N2
Enrollment
44
Registered
2021-01-16
Start date
2021-01-19
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone marrow disease. Multiple myeloma and malignant plasma cell neoplasms

Interventions

Intervention 1: Intervention group: 1. Infusion of one gram ampoule in 100 cc of normal saline serum half an hour before the procedure 2. 5 cc of promethazine syrup (25 mg) 30 minutes before the pr

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Age 18-55 years Conscious consent to enter the study BMI 18-25

Exclusion criteria

Exclusion criteria: Mental retardation Generalized anxiety disorder Major Depressive Disorder Pregnancy Lactation Drug addiction Take analgesic less than 4 hours before admission Hypersensitivity to apotel, promethazine and lidocaine GFR < 30 Cirrhosis Child B & C

Design outcomes

Primary

MeasureTime frame
Reduction of pain during bone marrow biopsy and aspiration. Timepoint: Immediately after completing the procedure and 30 minutes later in the intervention and control groups. Method of measurement: To estimate the severity of pain and the effect of the drug in relieving the patient's pain from the quantitative scale VAS(Visual Analog Scale) is used.;Anxiety after completing the procedure. Timepoint: After the procedure and 30 minutes later, the patient's anxiety is rated from 1 to 10, depending on the severity. Method of measurement: Anxiety severity is divided from zero to ten using a questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Darakhshandeh

Esfahan University of Medical Sciences

alidarakhshandeh@med.mui.ac.ir+98 31 3777 2640

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026